Clinical Trial Update: Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling

View source ↗

Summary

Clinical trial NCT03760952 investigating Human Leukocyte Antigen typing and tumor antigen expression profiling by Immatics US, Inc. has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Immatics US, Inc. | Conditions: Refractory Cancer, Recurrent Cancer | Status: COMPLETED